152 related articles for article (PubMed ID: 37432613)
1. Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis.
Nakashima T; Arigami T; Uenosono Y; Matsushita D; Shimonosono M; Tsuruda Y; Sasaki K; Baba K; Kurahara H; Ohtsuka T
Int J Clin Oncol; 2023 Oct; 28(10):1371-1377. PubMed ID: 37432613
[TBL] [Abstract][Full Text] [Related]
2. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study.
Yang Z; Lu S; Shi M; Yuan H; Wang Z; Ni Z; He C; Zheng Y; Zhu Z; Liu W; Yao X; Zhang J; Li C; Yan M; Yan C; Zhu Z
Gastric Cancer; 2024 Mar; 27(2):387-399. PubMed ID: 38143257
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of conversion surgery after a single intraperitoneal administration of paclitaxel and systemic chemotherapy for gastric cancer with peritoneal metastasis.
Shinkai M; Imano M; Hiraki Y; Momose K; Kato H; Shiraishi O; Yasuda A; Tsubaki M; Nishida S; Yasuda T
Langenbecks Arch Surg; 2022 May; 407(3):975-983. PubMed ID: 34988644
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Chia DKA; Sundar R; Kim G; Ang JJ; Lum JHY; Nga ME; Goh GH; Seet JE; Chee CE; Tan HL; Ho J; Ngoi NYL; Lee MXW; Muthu V; Chan GHJ; Pang ASL; Ang YLE; Choo JRE; Lim JSJ; Teh JL; Lwin A; Soon Y; Shabbir A; So JBY; Yong WP
Ann Surg Oncol; 2022 Dec; 29(13):8597-8605. PubMed ID: 36070113
[TBL] [Abstract][Full Text] [Related]
5. Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
Ishigami H; Fujiwara Y; Fukushima R; Nashimoto A; Yabusaki H; Imano M; Imamoto H; Kodera Y; Uenosono Y; Amagai K; Kadowaki S; Miwa H; Yamaguchi H; Yamaguchi T; Miyaji T; Kitayama J
J Clin Oncol; 2018 Jul; 36(19):1922-1929. PubMed ID: 29746229
[TBL] [Abstract][Full Text] [Related]
6. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
7. Conversion surgery in patients with pancreatic cancer and peritoneal metastasis.
Yamada S; Fujii T; Yamamoto T; Takami H; Yoshioka I; Yamaki S; Sonohara F; Shibuya K; Motoi F; Hirano S; Murakami Y; Inoue H; Hayashi M; Hashimoto D; Murotani K; Kitayama J; Ishikawa H; Kodera Y; Sekimoto M; Satoi S
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S110-S117. PubMed ID: 33968431
[TBL] [Abstract][Full Text] [Related]
8. Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy.
Kim S; Lee CM; Lee D; Kim JH; Park S; Park SH
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565463
[TBL] [Abstract][Full Text] [Related]
9. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
[No Abstract] [Full Text] [Related]
10. Clinical Significance of Conversion Surgery for Gastric Cancer with Peritoneal Dissemination: A Retrospective Study.
Arigami T; Matsushita D; Okubo K; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Yanagita S; Uenosono Y; Ishigami S; Ohtsuka T; Natsugoe S
Oncology; 2020; 98(11):798-806. PubMed ID: 32906117
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis.
Chen Y; Tang WF; Lin J; Shi Y; Wang XJ; Chen Q; Guo ZQ
Int J Clin Exp Med; 2015; 8(10):18620-8. PubMed ID: 26770475
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intraperitoneal and intravenous chemotherapy for advanced gastric cancer with peritoneal metastasis.
Chen Y; Wang XJ; Lin RB; Chen L; Lin G; Guo ZQ
Tumori; 2014; 100(5):e180-8. PubMed ID: 25343556
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
[TBL] [Abstract][Full Text] [Related]
15. Study of SOX combined with intraperitoneal high-dose paclitaxel in gastric cancer with synchronous peritoneal metastasis: A phase II single-arm clinical trial.
Tu L; Zhang W; Ni L; Xu Z; Yang K; Gou H; Zhu Q; Liu M; Yang Y; Hu J; Qiu M
Cancer Med; 2023 Feb; 12(4):4161-4169. PubMed ID: 36161282
[TBL] [Abstract][Full Text] [Related]
16. Benefits of Surgery After Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients With Peritoneal Metastasis: A Meta-Analysis.
Gong Y; Wang P; Zhu Z; Zhang J; Huang J; Wang T; Chen J; Xu H
J Surg Res; 2020 Jan; 245():234-243. PubMed ID: 31421368
[TBL] [Abstract][Full Text] [Related]
17. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
Kobayashi D; Ishigami H; Kanda M; Tanaka C; Yamaguchi H; Kitayama J; Kodera Y
Oncology; 2020; 98(1):48-52. PubMed ID: 31487733
[TBL] [Abstract][Full Text] [Related]
18. S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.
Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S
Gastrointest Cancer Res; 2012 May; 5(3 Suppl 1):S10-3. PubMed ID: 22876333
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal paclitaxel combined with FOLFOX/CAPOX plus bevacizumab for colorectal cancer with peritoneal carcinomatosis (the iPac-02 trial): study protocol of a single arm, multicenter, phase 2 study.
Murono K; Yokoyama Y; Nozawa H; Sasaki K; Emoto S; Matsuzaki H; Kashiwabara K; Ishigami H; Gohda Y; Yamaguchi H; Kitayama J; Ishihara S
Int J Colorectal Dis; 2023 Jun; 38(1):173. PubMed ID: 37340243
[TBL] [Abstract][Full Text] [Related]
20. Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis.
Kim DW; Jee YS; Kim CH; Kim JJ; Park S; Choi SI; Park JM; Kim JH;
J Gastric Cancer; 2020 Mar; 20(1):50-59. PubMed ID: 32269844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
